Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Net Income: 2010-2024

Historic Net Income for Whitehawk Therapeutics (WHWK) over the last 13 years, with Dec 2024 value amounting to -$63.7 million.

  • Whitehawk Therapeutics' Net Income fell 41.06% to -$17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$103.2 million, marking a year-over-year decrease of 67.25%. This contributed to the annual value of -$63.7 million for FY2024, which is 3.15% up from last year.
  • Whitehawk Therapeutics' Net Income amounted to -$63.7 million in FY2024, which was up 3.15% from -$65.8 million recorded in FY2023.
  • Whitehawk Therapeutics' Net Income's 5-year high stood at -$3.5 million during FY2020, with a 5-year trough of -$110.1 million in FY2021.
  • Over the past 3 years, Whitehawk Therapeutics' median Net Income value was -$63.7 million (recorded in 2024), while the average stood at -$63.3 million.
  • Per our database at Business Quant, Whitehawk Therapeutics' Net Income soared by 85.15% in 2020 and then tumbled by 3,065.32% in 2021.
  • Over the past 5 years, Whitehawk Therapeutics' Net Income (Yearly) stood at -$3.5 million in 2020, then slumped by 3,065.32% to -$110.1 million in 2021, then soared by 45.03% to -$60.5 million in 2022, then decreased by 8.68% to -$65.8 million in 2023, then grew by 3.15% to -$63.7 million in 2024.